Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4015 USD | -0.37% | -5.28% | -8.73% |
05-16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 | |
04-29 | AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed | MT |
- Stock Market
- Equities
- AIM Stock
- Charts AIM ImmunoTech Inc.
- Static Chart